U.K. says AstraZeneca alternative should be offered for under 30s, and E.U. finds a ‘possible link’ to rare clots.

The move follows concerns about rare blood clots in some vaccine recipients. European regulators found a “possible link” to the clots, but said that the vaccine’s benefits still outweighed the risks.

from NYT > World News https://ift.tt/3d1X8j7
via IFTTT